cytarabine has been researched along with sesquiterpenes in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barlogie, B; Drewinko, B; Hromas, R; Swartzendruber, D | 1 |
Barlogie, B; Drewinko, B; Mauro, F; Swartzendruber, D; Teodori, L | 1 |
Tallman, M | 1 |
Iranshahi, M; Nasseri, MA; Taleghani, A | 1 |
4 other study(ies) available for cytarabine and sesquiterpenes
Article | Year |
---|---|
Selective protection by anguidine of normal versus transformed cells against 1-beta-D-arabinofuranosylcytosine and Adriamycin.
Topics: Cell Cycle; Cell Division; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cytarabine; Doxorubicin; Humans; Sesquiterpenes; Trichothecenes | 1983 |
Reduction of 1-beta-D-arabinofuranosylcytosine and adriamycin cytotoxicity following cell cycle arrest by anguidine.
Topics: Animals; Cell Cycle; Cell Line; Cell Survival; Cricetinae; Cricetulus; Cytarabine; DNA; Doxorubicin; Drug Interactions; Female; Mitosis; Ovary; Sesquiterpenes; Time Factors; Trichothecenes | 1981 |
Existing and emerging therapeutic options for the treatment of acute myeloid leukemia.
Topics: Adenine; Adenine Nucleotides; Aminoglycosides; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Arabinonucleosides; Carbazoles; Clofarabine; Cytarabine; Dasatinib; Daunorubicin; fms-Like Tyrosine Kinase 3; Furans; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Naphthalimides; Organophosphonates; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Sesquiterpenes; Staurosporine; Stem Cell Transplantation; Thiazoles; Tretinoin | 2008 |
Synthesis of dual-action parthenolide prodrugs as potent anticancer agents.
Topics: Antineoplastic Agents; Apoptosis; Catalysis; Cell Line, Tumor; Chemistry Techniques, Synthetic; Cytarabine; Humans; Lactones; Melphalan; Neoplasms; Prodrugs; Sesquiterpenes | 2017 |